Literature DB >> 7912462

Multiple receptors for PACAP and VIP.

T Harmar1, E Lutz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7912462     DOI: 10.1016/0165-6147(94)90042-6

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  22 in total

1.  Granule cell survival is deficient in PAC1-/- mutant cerebellum.

Authors:  Anthony Falluel-Morel; Liana I Tascau; Katie Sokolowski; Philippe Brabet; Emanuel DiCicco-Bloom
Journal:  J Mol Neurosci       Date:  2008-04-12       Impact factor: 3.444

Review 2.  A VIP hybrid antagonist: from developmental neurobiology to clinical applications.

Authors:  I Gozes; M Fridkin; D E Brenneman
Journal:  Cell Mol Neurobiol       Date:  1995-12       Impact factor: 5.046

3.  Nickel suppresses the PACAP-induced increase in guinea pig cardiac neuron excitability.

Authors:  John D Tompkins; Laura A Merriam; Beatrice M Girard; Victor May; Rodney L Parsons
Journal:  Am J Physiol Cell Physiol       Date:  2015-03-25       Impact factor: 4.249

4.  Expression of pituitary adenylate cyclase-activating peptide (PACAP) and PAC1 in the periodontal ligament after tooth luxation.

Authors:  Sayako Nonaka; Hideki Kitaura; Keisuke Kimura; Masahiko Ishida; Teruko Takano-Yamamoto
Journal:  Cell Mol Neurobiol       Date:  2013-06-26       Impact factor: 5.046

5.  Activation of MEK/ERK signaling contributes to the PACAP-induced increase in guinea pig cardiac neuron excitability.

Authors:  John D Tompkins; Todd A Clason; Jean C Hardwick; Beatrice M Girard; Laura A Merriam; Victor May; Rodney L Parsons
Journal:  Am J Physiol Cell Physiol       Date:  2016-08-03       Impact factor: 4.249

6.  Identification of VIP/PACAP receptors on rat astrocytes using antisense oligodeoxynucleotides.

Authors:  O Ashur-Fabian; E Giladi; D E Brenneman; I Gozes
Journal:  J Mol Neurosci       Date:  1997-12       Impact factor: 3.444

7.  Mapping the active site in vasoactive intestinal peptide to a core of four amino acids: neuroprotective drug design.

Authors:  I Gozes; O Perl; E Giladi; A Davidson; O Ashur-Fabian; S Rubinraut; M Fridkin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

8.  Pituitary adenylate cyclase-activating polypeptide expression and modulation of neuronal excitability in guinea pig cardiac ganglia.

Authors:  K M Braas; V May; S A Harakall; J C Hardwick; R L Parsons
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

9.  Comparative effects of PACAP and VIP on pancreatic endocrine secretions and vascular resistance in rat.

Authors:  G Bertrand; R Puech; Y Maisonnasse; J Bockaert; M M Loubatières-Mariani
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

10.  Pituitary adenylate-cyclase-activating polypeptide (PACAP) binding sites and PACAP/vasoactive intestinal polypeptide receptor expression in human pituitary adenomas.

Authors:  H Oka; L Jin; J C Reubi; X Qian; B W Scheithauer; K Fujii; T Kameya; R V Lloyd
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.